These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 20199441
1. The frequency and intensity of topical pimecrolimus treatment in children with physician-confirmed mild to moderate atopic dermatitis. Kapoor R, Hoffstad O, Bilker W, Margolis DJ. Pediatr Dermatol; 2009; 26(6):682-7. PubMed ID: 20199441 [Abstract] [Full Text] [Related]
2. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Hebert AA. Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454 [Abstract] [Full Text] [Related]
3. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K. J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [Abstract] [Full Text] [Related]
4. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. Siegfried E, Korman N, Molina C, Kianifard F, Abrams K. J Dermatolog Treat; 2006 Aug; 17(3):143-50. PubMed ID: 16854753 [Abstract] [Full Text] [Related]
8. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis. Sigurgeirsson B, Ho V, Ferrándiz C, Andriano K, Grinienko A, Jimenez P, Pimecrolimus 1% cream in (paediatric) Eczema: Prevention of Progression multi-centre investigator study group. J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866 [Abstract] [Full Text] [Related]
9. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. Kirsner RS, Heffernan MP, Antaya R. Acta Derm Venereol; 2010 Nov; 90(1):58-64. PubMed ID: 20107727 [Abstract] [Full Text] [Related]
10. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis. Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989 [Abstract] [Full Text] [Related]
11. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis. Frankel A, Sohn A, Patel RV, Lebwohl M. J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908 [Abstract] [Full Text] [Related]
16. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T. Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708 [Abstract] [Full Text] [Related]
20. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis. De Backer M, Morren MA, Boonen H, Boyden B, Vertruyen A, Lecomte P, Paquay C, Lesaffre E, Lambert J. Dermatology; 2008 Feb; 217(2):156-63. PubMed ID: 18525202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]